TriSalus Life Sciences, Inc. SEC filings TLSI
TriSalus Life Sciences, Inc. has 493 filings in SEC EDGAR's recent list, going back to Oct 29, 2020. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 4, 2025 | — |
| CORRESP | Letter to the SEC | Dec 2, 2025 | — |
| SC TO-I/A | Filing | Jul 25, 2025 | — |
| EFFECT | Filing | Jul 22, 2025 | — |
| SC TO-I/A | Filing | Jul 15, 2025 | — |
| SC TO-I | Filing | Jun 23, 2025 | — |
| EFFECT | Filing | Jun 11, 2025 | — |
| CORRESP | Letter to the SEC | Jun 6, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2025 | — |
| EFFECT | Filing | May 30, 2025 | — |
| CORRESP | Letter to the SEC | May 28, 2025 | — |
| D | Filing | May 8, 2025 | — |
| UPLOAD | Letter from the SEC | May 5, 2025 | — |
| EFFECT | Filing | May 2, 2025 | — |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2025 | — |
| 425 | Filing | Apr 30, 2025 | — |
| NT 10-K | Filing | Mar 28, 2025 | Dec 31, 2024 |
| D | Filing | Dec 30, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 6, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2024 | — |
| 425 | Filing | Jul 1, 2024 | — |
| SC TO-I/A | Filing | Jun 27, 2024 | — |
| 425 | Filing | Jun 27, 2024 | — |
| EFFECT | Filing | Jun 25, 2024 | — |
| EFFECT | Filing | Jun 21, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2024 | — |
| SC TO-I | Filing | May 24, 2024 | — |
| 425 | Filing | May 24, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| NT 10-K | Filing | Apr 2, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Dec 26, 2023 | — |
| EFFECT | Filing | Dec 26, 2023 | — |
| CORRESP | Letter to the SEC | Dec 21, 2023 | — |
| CORRESP | Letter to the SEC | Dec 21, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2023 | — |
| CORRESP | Letter to the SEC | Dec 14, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2023 | — |
| CORRESP | Letter to the SEC | Oct 18, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 28, 2023 | — |
| 25-NSE | Delisting notice | Aug 10, 2023 | — |
| 425 | Filing | Aug 9, 2023 | — |
| 425 | Filing | Aug 2, 2023 | — |
| 425 | Filing | Aug 2, 2023 | — |
| SEC STAFF LETTER | Filing | Jul 18, 2023 | — |
| EFFECT | Filing | Jul 18, 2023 | — |
| CORRESP | Letter to the SEC | Jul 14, 2023 | — |
| CORRESP | Letter to the SEC | Jul 6, 2023 | — |
| 425 | Filing | Jul 6, 2023 | — |
| D | Filing | Jun 22, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2023 | — |
| 425 | Filing | Jun 12, 2023 | — |
| CORRESP | Letter to the SEC | Jun 8, 2023 | — |
| 425 | Filing | Jun 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 31, 2023 | — |
| SEC STAFF LETTER | Filing | May 25, 2023 | — |
| CORRESP | Letter to the SEC | May 23, 2023 | — |
| 425 | Filing | May 15, 2023 | — |
| UPLOAD | Letter from the SEC | May 3, 2023 | — |
| CORRESP | Letter to the SEC | Apr 21, 2023 | — |
| 425 | Filing | Apr 20, 2023 | — |
| 425 | Filing | Apr 5, 2023 | — |
| 425 | Filing | Mar 8, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2023 | — |
| 425 | Filing | Feb 21, 2023 | — |
| 425 | Filing | Feb 16, 2023 | — |
| CORRESP | Letter to the SEC | Feb 14, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2023 | — |
| 425 | Filing | Dec 21, 2022 | — |
| 425 | Filing | Dec 19, 2022 | — |
| 425 | Filing | Dec 15, 2022 | — |
| 425 | Filing | Dec 8, 2022 | — |
| 425 | Filing | Nov 21, 2022 | — |
| 425 | Filing | Nov 14, 2022 | — |
| 425 | Filing | Nov 14, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2022 | — |
| CORRESP | Letter to the SEC | Sep 22, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2022 | — |
| 425 | Filing | Feb 23, 2022 | — |
| 425 | Filing | Jan 6, 2022 | — |
| 425 | Filing | Sep 9, 2021 | — |
| 425 | Filing | Sep 9, 2021 | — |
| 425 | Form 8-k | Aug 13, 2021 | — |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| EFFECT | Filing | Dec 17, 2020 | — |
| CERT | Filing | Dec 17, 2020 | — |
| 8-A12B | Filing | Dec 16, 2020 | — |
| DRS | Filing | Oct 29, 2020 | — |
Showing 94 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TLSI (Nasdaq), TLSIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westminster, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1826667
- Former names
- MedTech Acquisition Corp (until Aug 10, 2023); MedTech Acquisition Corporation (until Oct 29, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.